Global and China Organ Transplant Immunosuppressant Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Oct-2020
No. of pages: 140
Inquire Before Buying

Organ Transplant Immunosuppressant Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Immunosuppressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Organ Transplant Immunosuppressant Drugs market is segmented into

Antibodies

Antiproliferative Agents

Calcineurin Inhibitors

mTOR Inhibitors

Steroids

Segment by Application, the Organ Transplant Immunosuppressant Drugs market is segmented into

Bone Marrow Transplant

Heart Transplant

Kidney Transplant

Liver Transplant

Lung Transplant

Regional and Country-level Analysis

The Organ Transplant Immunosuppressant Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Organ Transplant Immunosuppressant Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Organ Transplant Immunosuppressant Drugs Market Share Analysis

Organ Transplant Immunosuppressant Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Organ Transplant Immunosuppressant Drugs business, the date to enter into the Organ Transplant Immunosuppressant Drugs market, Organ Transplant Immunosuppressant Drugs product introduction, recent developments, etc.

The major vendors covered:

F. Hoffmann-La Roche Ltd.

Sanofi

AbbVie, Inc.

Allergan plc.

Astellas Pharma, Inc.

Bristol-Myers Squibb Company

Hoffmann-La Roche Ltd.

GlaxoSmithKline plc

Janssen Pharmaceutical

Novartis AG

Pfizer, Inc.

Veloxis Pharmaceuticals

Global and China Organ Transplant Immunosuppressant Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Organ Transplant Immunosuppressant Drugs Product Introduction
1.2 Market Segments
1.3 Key Organ Transplant Immunosuppressant Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Type
1.4.2 Antibodies
1.4.3 Antiproliferative Agents
1.4.4 Calcineurin Inhibitors
1.4.5 mTOR Inhibitors
1.4.6 Steroids
1.5 Market by Application
1.5.1 Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Application
1.5.2 Bone Marrow Transplant
1.5.3 Heart Transplant
1.5.4 Kidney Transplant
1.5.5 Liver Transplant
1.5.6 Lung Transplant
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Organ Transplant Immunosuppressant Drugs Market Size, Estimates and Forecasts
2.1.1 Global Organ Transplant Immunosuppressant Drugs Revenue 2015-2026
2.1.2 Global Organ Transplant Immunosuppressant Drugs Sales 2015-2026
2.2 Global Organ Transplant Immunosuppressant Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Organ Transplant Immunosuppressant Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Organ Transplant Immunosuppressant Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Region (2021-2026)
3 Global Organ Transplant Immunosuppressant Drugs Competitor Landscape by Players
3.1 Global Top Organ Transplant Immunosuppressant Drugs Sales by Manufacturers
3.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Organ Transplant Immunosuppressant Drugs Manufacturers by Revenue
3.2.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Organ Transplant Immunosuppressant Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Organ Transplant Immunosuppressant Drugs Revenue in 2019
3.2.5 Global Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Organ Transplant Immunosuppressant Drugs Price by Manufacturers
3.4 Global Organ Transplant Immunosuppressant Drugs Manufacturing Base Distribution, Product Types
3.4.1 Organ Transplant Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Type (2015-2020)
4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2015-2020)
4.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2015-2020)
4.1.3 Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Organ Transplant Immunosuppressant Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Organ Transplant Immunosuppressant Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Application (2015-2020)
5.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2015-2020)
5.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2015-2020)
5.1.3 Organ Transplant Immunosuppressant Drugs Price by Application (2015-2020)
5.2 Organ Transplant Immunosuppressant Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Organ Transplant Immunosuppressant Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2015-2026
6.1.1 China Organ Transplant Immunosuppressant Drugs Sales YoY Growth 2015-2026
6.1.2 China Organ Transplant Immunosuppressant Drugs Revenue YoY Growth 2015-2026
6.1.3 China Organ Transplant Immunosuppressant Drugs Market Share in Global Market 2015-2026
6.2 China Organ Transplant Immunosuppressant Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Organ Transplant Immunosuppressant Drugs Players by Sales (2015-2020)
6.2.2 China Top Organ Transplant Immunosuppressant Drugs Players by Revenue (2015-2020)
6.3 China Organ Transplant Immunosuppressant Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Organ Transplant Immunosuppressant Drugs Price by Type (2015-2020)
6.4 China Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Organ Transplant Immunosuppressant Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Organ Transplant Immunosuppressant Drugs Price Forecast by Type (2021-2026)
6.5 China Organ Transplant Immunosuppressant Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Organ Transplant Immunosuppressant Drugs Price by Application (2015-2020)
6.6 China Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Organ Transplant Immunosuppressant Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2015-2026
7.2 North America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
7.2.1 North America Organ Transplant Immunosuppressant Drugs Sales by Country (2015-2020)
7.2.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2015-2026
8.2 Europe Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
8.2.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Country
8.2.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
10.2.1 Latin America Organ Transplant Immunosuppressant Drugs Sales by Country
10.2.2 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country
11.2.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 F. Hoffmann-La Roche Ltd.
12.1.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.1.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.1.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Products Offered
12.1.5 F. Hoffmann-La Roche Ltd. Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 AbbVie, Inc.
12.3.1 AbbVie, Inc. Corporation Information
12.3.2 AbbVie, Inc. Description and Business Overview
12.3.3 AbbVie, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
12.3.5 AbbVie, Inc. Recent Development
12.4 Allergan plc.
12.4.1 Allergan plc. Corporation Information
12.4.2 Allergan plc. Description and Business Overview
12.4.3 Allergan plc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Allergan plc. Organ Transplant Immunosuppressant Drugs Products Offered
12.4.5 Allergan plc. Recent Development
12.5 Astellas Pharma, Inc.
12.5.1 Astellas Pharma, Inc. Corporation Information
12.5.2 Astellas Pharma, Inc. Description and Business Overview
12.5.3 Astellas Pharma, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
12.5.5 Astellas Pharma, Inc. Recent Development
12.6 Bristol-Myers Squibb Company
12.6.1 Bristol-Myers Squibb Company Corporation Information
12.6.2 Bristol-Myers Squibb Company Description and Business Overview
12.6.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Products Offered
12.6.5 Bristol-Myers Squibb Company Recent Development
12.7 Hoffmann-La Roche Ltd.
12.7.1 Hoffmann-La Roche Ltd. Corporation Information
12.7.2 Hoffmann-La Roche Ltd. Description and Business Overview
12.7.3 Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Products Offered
12.7.5 Hoffmann-La Roche Ltd. Recent Development
12.8 GlaxoSmithKline plc
12.8.1 GlaxoSmithKline plc Corporation Information
12.8.2 GlaxoSmithKline plc Description and Business Overview
12.8.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Products Offered
12.8.5 GlaxoSmithKline plc Recent Development
12.9 Janssen Pharmaceutical
12.9.1 Janssen Pharmaceutical Corporation Information
12.9.2 Janssen Pharmaceutical Description and Business Overview
12.9.3 Janssen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Products Offered
12.9.5 Janssen Pharmaceutical Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Description and Business Overview
12.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis AG Organ Transplant Immunosuppressant Drugs Products Offered
12.10.5 Novartis AG Recent Development
12.11 F. Hoffmann-La Roche Ltd.
12.11.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.11.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.11.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Products Offered
12.11.5 F. Hoffmann-La Roche Ltd. Recent Development
12.12 Veloxis Pharmaceuticals
12.12.1 Veloxis Pharmaceuticals Corporation Information
12.12.2 Veloxis Pharmaceuticals Description and Business Overview
12.12.3 Veloxis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Veloxis Pharmaceuticals Products Offered
12.12.5 Veloxis Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Organ Transplant Immunosuppressant Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Organ Transplant Immunosuppressant Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Organ Transplant Immunosuppressant Drugs Market Segments
Table 2. Ranking of Global Top Organ Transplant Immunosuppressant Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Antibodies
Table 5. Major Manufacturers of Antiproliferative Agents
Table 6. Major Manufacturers of Calcineurin Inhibitors
Table 7. Major Manufacturers of mTOR Inhibitors
Table 8. Major Manufacturers of Steroids
Table 9. Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 10. Global Organ Transplant Immunosuppressant Drugs Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 11. Global Organ Transplant Immunosuppressant Drugs Sales by Regions 2015-2020 (K Doses)
Table 12. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Organ Transplant Immunosuppressant Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Region (2021-2026) (K Doses)
Table 15. Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015-2020) (K Doses)
Table 16. Global Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Organ Transplant Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Organ Transplant Immunosuppressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2019)
Table 19. Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Organ Transplant Immunosuppressant Drugs Price (2015-2020) (USD/ Dose)
Table 22. Organ Transplant Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
Table 24. Date of International Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2015-2020) (K Doses)
Table 27. Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2015-2020)
Table 28. Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2015-2020)
Table 30. Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/ Dose)
Table 31. Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2021-2026)
Table 32. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2015-2020) (K Doses)
Table 33. Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2015-2020)
Table 34. Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2021-2026)
Table 35. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 38. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) of Key Companies (2015-2020)
Table 39. China Organ Transplant Immunosuppressant Drugs Sales Share by Company (2015-2020)
Table 40. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Company (2015-2020)
Table 41. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 42. China Organ Transplant Immunosuppressant Drugs Sales Share by Type (2015-2020)
Table 43. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. China Organ Transplant Immunosuppressant Drugs Price (K Doses) by Type (2015-2020)
Table 45. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2021-2026)
Table 46. China Organ Transplant Immunosuppressant Drugs Sales Share by Type (2021-2026)
Table 47. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. China Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2021-2026)
Table 49. China Organ Transplant Immunosuppressant Drugs Price (K Doses) by Type (2021-2026)
Table 50. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2015-2020)
Table 51. China Organ Transplant Immunosuppressant Drugs Sales Share by Application (2015-2020)
Table 52. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2021-2026)
Table 54. China Organ Transplant Immunosuppressant Drugs Sales Share by Application (2021-2026)
Table 55. China Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. China Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2021-2026)
Table 57. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2015-2020) (K Doses)
Table 58. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 59. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 61. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2015-2020) (K Doses)
Table 62. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 63. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2015-2020) (K Doses)
Table 66. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2015-2020)
Table 69. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2015-2020) (K Doses)
Table 70. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Organ Transplant Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2015-2020) (K Doses)
Table 74. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 77. F. Hoffmann-La Roche Ltd. Corporation Information
Table 78. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 79. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 80. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product
Table 81. F. Hoffmann-La Roche Ltd. Recent Development
Table 82. Sanofi Corporation Information
Table 83. Sanofi Description and Business Overview
Table 84. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 85. Sanofi Product
Table 86. Sanofi Recent Development
Table 87. AbbVie, Inc. Corporation Information
Table 88. AbbVie, Inc. Description and Business Overview
Table 89. AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 90. AbbVie, Inc. Product
Table 91. AbbVie, Inc. Recent Development
Table 92. Allergan plc. Corporation Information
Table 93. Allergan plc. Description and Business Overview
Table 94. Allergan plc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 95. Allergan plc. Product
Table 96. Allergan plc. Recent Development
Table 97. Astellas Pharma, Inc. Corporation Information
Table 98. Astellas Pharma, Inc. Description and Business Overview
Table 99. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 100. Astellas Pharma, Inc. Product
Table 101. Astellas Pharma, Inc. Recent Development
Table 102. Bristol-Myers Squibb Company Corporation Information
Table 103. Bristol-Myers Squibb Company Description and Business Overview
Table 104. Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 105. Bristol-Myers Squibb Company Product
Table 106. Bristol-Myers Squibb Company Recent Development
Table 107. Hoffmann-La Roche Ltd. Corporation Information
Table 108. Hoffmann-La Roche Ltd. Description and Business Overview
Table 109. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 110. Hoffmann-La Roche Ltd. Product
Table 111. Hoffmann-La Roche Ltd. Recent Development
Table 112. GlaxoSmithKline plc Corporation Information
Table 113. GlaxoSmithKline plc Description and Business Overview
Table 114. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 115. GlaxoSmithKline plc Product
Table 116. GlaxoSmithKline plc Recent Development
Table 117. Janssen Pharmaceutical Corporation Information
Table 118. Janssen Pharmaceutical Description and Business Overview
Table 119. Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 120. Janssen Pharmaceutical Product
Table 121. Janssen Pharmaceutical Recent Development
Table 122. Novartis AG Corporation Information
Table 123. Novartis AG Description and Business Overview
Table 124. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 125. Novartis AG Product
Table 126. Novartis AG Recent Development
Table 127. Pfizer, Inc. Corporation Information
Table 128. Pfizer, Inc. Description and Business Overview
Table 129. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 130. Pfizer, Inc. Product
Table 131. Pfizer, Inc. Recent Development
Table 132. Veloxis Pharmaceuticals Corporation Information
Table 133. Veloxis Pharmaceuticals Description and Business Overview
Table 134. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 135. Veloxis Pharmaceuticals Product
Table 136. Veloxis Pharmaceuticals Recent Development
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Organ Transplant Immunosuppressant Drugs Players
Table 141. Organ Transplant Immunosuppressant Drugs Customers List
Table 142. Organ Transplant Immunosuppressant Drugs Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Drugs Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Antibodies Product Picture
Figure 4. Antiproliferative Agents Product Picture
Figure 5. Calcineurin Inhibitors Product Picture
Figure 6. mTOR Inhibitors Product Picture
Figure 7. Steroids Product Picture
Figure 8. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Bone Marrow Transplant
Figure 10. Heart Transplant
Figure 11. Kidney Transplant
Figure 12. Liver Transplant
Figure 13. Lung Transplant
Figure 14. Organ Transplant Immunosuppressant Drugs Report Years Considered
Figure 15. Global Organ Transplant Immunosuppressant Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Organ Transplant Immunosuppressant Drugs Sales 2015-2026 (K Doses)
Figure 17. Global Organ Transplant Immunosuppressant Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region in 2019
Figure 20. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region in 2019
Figure 22. Global Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Organ Transplant Immunosuppressant Drugs Revenue in 2019
Figure 24. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 27. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type in 2019
Figure 29. Global Organ Transplant Immunosuppressant Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2019
Figure 32. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application in 2019
Figure 34. China Organ Transplant Immunosuppressant Drugs Sales Growth Rate 2015-2026 (K Doses)
Figure 35. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. China Organ Transplant Immunosuppressant Drugs Market Share in Global Market 2015-2026
Figure 37. China 5 and 10 Largest Organ Transplant Immunosuppressant Drugs Players Market Share by Revenue in Organ Transplant Immunosuppressant Drugs in 2019
Figure 38. China Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2015-2020)
Figure 39. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 40. China Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2015-2020)
Figure 41. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Organ Transplant Immunosuppressant Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 43. North America Organ Transplant Immunosuppressant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country in 2019
Figure 45. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country in 2019
Figure 46. U.S. Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.S. Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Canada Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Organ Transplant Immunosuppressant Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 51. Europe Organ Transplant Immunosuppressant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Country in 2019
Figure 53. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country in 2019
Figure 54. Germany Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Germany Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 57. France Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K.
  • COVID-19 World Indomethacin Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 22-Oct-2020        Price: US 2800 Onwards        Pages: 108
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Indomethacin , covering Global total and......
  • Global and China Topiramate Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 131
    Topiramate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Topiramate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Topiramate market is segmented into - 0.98......
  • Global and Japan Lincomycin Hydrochloride Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 127
    Lincomycin Hydrochloride market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lincomycin Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Lincomycin Hydrochlorid......
  • Global and China Pinaverium Bromide Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 127
    Pinaverium Bromide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pinaverium Bromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Pinaverium Bromide market is segmen......
  • Global and Japan Tamoxifen Citrate Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 133
    Tamoxifen Citrate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tamoxifen Citrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Tamoxifen Citrate market is segmented......
  • 2020-2029 Report on Global Primary Immunodeficiency Diseases Treatment Market by Player, Region, Type, Application and Sales Channel
    Published: 22-Oct-2020        Price: US 2500 Onwards        Pages: 135
    The global Primary Immunodeficiency Diseases Treatment market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will signif......
  • 2020-2029 Report on Global Antibody Drug Conjugate Market by Player, Region, Type, Application and Sales Channel
    Published: 22-Oct-2020        Price: US 2500 Onwards        Pages: 135
    The global Antibody Drug Conjugate market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this ......
  • (Post-pandemic Era) - Global Rotavirus Vaccine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 21-Oct-2020        Price: US 4860 Onwards        Pages: 89
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Rotavirus Vaccine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related......
  • (Post-pandemic Era) - Global Rotavirus Vaccine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 21-Oct-2020        Price: US 3650 Onwards        Pages: 104
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs